Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.300 |
None |
|
0 |
|
|
|
Neoplasm of uncertain or unknown behavior of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
|
0 |
|
|
|
Breast adenocarcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
219
|
7
|
0.300 |
None |
|
0 |
|
|
|
Salivary duct carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
54
|
9
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.020 |
None |
0.500 |
2 |
|
2009 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.400 |
None |
0.938 |
16 |
|
2005 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.976 |
42 |
|
2007 |
2020 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.600 |
None |
0.986 |
71 |
|
2004 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.600 |
None |
0.986 |
69 |
|
2004 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.400 |
None |
1.000 |
35 |
|
2007 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
30 |
|
2009 |
2020 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
1.000 |
29 |
|
2009 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
26 |
|
2009 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
16 |
|
2012 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
14 |
|
2010 |
2019 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.100 |
None |
1.000 |
12 |
|
2006 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
11 |
|
2009 |
2019 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.090 |
None |
1.000 |
9 |
|
2011 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.080 |
None |
1.000 |
8 |
|
2004 |
2019 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.080 |
None |
1.000 |
8 |
|
2004 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.080 |
None |
1.000 |
8 |
|
2012 |
2020 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.080 |
None |
1.000 |
8 |
|
2004 |
2019 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.070 |
None |
1.000 |
7 |
|
2015 |
2020 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.330 |
None |
1.000 |
7 |
|
2008 |
2019 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.070 |
None |
1.000 |
7 |
|
2015 |
2020 |